BioCentury
ARTICLE | Company News

Avigen gene/cell therapy news

October 28, 2002 8:00 AM UTC

AVGN reduced its workforce to 110 from 152 under a restructuring plan to extend its cash position and will incur a restructuring charge of about $500,000, which AVGN will report in the fourth quarter....